Global Cancer Diagnostic Market

Cancer is one of the prime fatal disease in the world. Its prevalence is increasingly found. This has forced advanced treatment techniques for this disease. Development of effective diagnostic tool are on high demand. Cancer can be treated more efficiently if detected at the early stage. Routine check-up is promoted by healthcare professional to identify the cancer in the early stages.

Market Dynamics

Global Cancer Diagnostic Market faces a great growth due to factor like the technological advancement in diagnostics such as imaging, bioscopy, endoscopy, etc. Also the increasing number of cancer cases among patients drives the market. The supporting role of the government through various initiatives and creating awareness also acts as a market driver. The risk factors due to exposure to the radiations and high cost pose a restraint to the market growth.

Market Segmentation

Global Cancer Diagnostic Market is segmented by product into Platform based and Instrument based. The Platform based can be further segmented in to PCR, Microarrays, Immunohistochemistry, In Situ Hybridization and Next generation sequencing. The instrument based can be sub divided in to Imaging instruments and Biopsy. The imaging instruments are MRI, CT, PET, Ultrasound and mammography. Based on application, it is segmented into Breast cancer, Lung cancer, Colorectal cancer, Melanoma and others.

Regional/Geographic Analysis

The Global Cancer Diagnostic Market is dominated by North America with the largest market share. This is due to the fact that huge number of biotechnology companies are present there. This region demands high advanced technologies and this acts as a driving force in the market. Asia Pacific is expected to face high growth due to the huge population and the patient pool. The medical tourism in this region will boost the market in this region.

Key Players

The key players in the Global Cancer Diagnostic Market are Agilent Technologies, Illumina, Dickinson and Company, Philips Healthcare, Siemens Healthcare, Becton, Abbott Laboratories, Roche Diagnostics, GE Healthcare, Thermo Fisher Scietific and QIAGEN.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage